CuspAI vs Profluent
A side-by-side comparison of CuspAI and Profluent, two Science tools, drawn from Ignaite's continuously-verified listings.
Compared from listings verified as of
CuspAI
ScienceAI platform that designs new materials on demand, like a search engine for molecules.
View CuspAIAt a glance
| Attribute | CuspAI | Profluent |
|---|---|---|
| Category | Science | Science |
| Pricing | PAID | PAID |
| License | Proprietary | Proprietary |
| Deployment | Cloud | Cloud |
| Platforms | Web | Web |
| Model support | — | — |
| Vendor (differs) | CuspAI | Profluent Bio |
| Capabilities (differs) |
|
|
The honest brief
CuspAI
Aims at carbon-capture and sustainability materials, fusing generative foundation models with molecular simulation in a single discovery loop.
- Co-founded by AI pioneer Max Welling
- Generative models plus simulation in one platform
- Heavily funded (~$130M total)
- NVIDIA, Samsung, Hyundai among backers
- Partnership-only, no self-serve
- Very young (founded 2024)
- No public product or pricing
- Narrow enterprise focus
Profluent
Pairs frontier protein LLMs with openly released designs like OpenCRISPR-1, while most peers keep AI-designed molecules proprietary.
- ProGen protein-LLM lineage
- Open-released gene editor
- Nature-published work
- Eli Lilly and IDT partnerships
- Partnership/licensing only
- No self-serve platform
- Open releases are sequences, not a service
- Opaque pricing
When to pick which
Both cover Molecular design.
Pick CuspAI if you need Materials discovery and Physics simulation.
- Materials discovery (secondary capability)
- Physics simulation (secondary capability)
Pick Profluent if you need Protein design and Antibody design.
- Protein design (primary capability)
- Antibody design (secondary capability)
CuspAI leans on Molecular design as a headline capability; Profluent treats it as secondary.
- Molecular design (primary capability)